REFERENCES
- Zimmerer R. O., Lindenbaum S. J. Pharm. Sci. 1979; 68: 581–585
- Mazer N. A., Benedek G. B., Carey M. C. Biochemistry. 1980; 19: 601–615
- Claffey W. J., Holzbach R. Biochemistry. 1981; 20: 415–418
- Müller K. Biochemistry. 1981; 20: 404–414
- Spink C. H., Müller K., Sturtevant J. M. Biochemistry. 1982; 21: 6598–6605
- Mazer N. A., Schurtenberger P., Carey M. C., Preisig R., Weigand K., Känzig W. Biochemistry. 1984; 23: 1994–2005
- Schurtenberger P., Mazer N. A., Känzig W. J. Phys. Chem. 1985; 89: 1042–1049
- Teelmann K., Schläppi B., Schüpbach M., Kistler A. Arzneim. Forsch./Drug Res. 1984; 34: 1517–1523
- Steffen H. Roche Magazin. 1984; 20: 2–9
- Rote Liste. Arzneimittelverzeichnis des BPI und VFA. Editio Cantor, Aulendorf 1995
- Alkan-Onyuksel H., Son K. Pharm. Res. 1992; 9: 1556–1562
- Alkan-Onyuksel H., Ramakrishnan S., Chai H., Pezzuto J. M. Pharm. Res. 1994; 11: 206–212
- Dürr M., Hager J., Löhr J. P. Eur. J. Pharm. Biopharm. 1994; 40: 147–156
- Rutger J. G., Shearer C. M. Lorazepam, in Analytical Profiles of Drug Substances, K. Florey. Academic Press, New York 1980; 9: 397–426
- Elworthy P. H., Patel M. S., Schearer R. P. J. Pharm. Pharmacol. 1983; 35: 55P
- Rosen J. M. Surfactants and Interfacial Phenomena. 1st ed., John Wiley and Sons, New York 1978; 127